This study aimed to assess the usability of NeuroTracker for patients with multiple sclerosis (MS).

What Was Studied

16 MS patients and 9 healthy age-matched controls performed four 30 minute NeuroTracker training sessions. A battery of neuropsychological tests were performed pre- and post-training (driving readiness, Stroop, PVSAT, SDMT).

What Was Found

While scoring lower on NeuroTracker, patients with MS improved their scores with very similar responsiveness to the healthy controls. The training also led to significant improvements in driving readiness, showing responsiveness to the training with similar effectiveness to healthy, age-matched controls.

Takeaways

The study highlights the potential of NeuroTracker training to enhance cognitive abilities in individuals with multiple sclerosis (MS). Despite lower initial scores, MS patients showed comparable responsiveness to the training as healthy controls. Furthermore, the training's positive impact on driving readiness suggests broader applications for cognitive improvement beyond the specific task trained.

‍

Reference: Sebastian Harenberg et al. ‘Effectiveness of Three-Dimensional Multiple-Object Tracking in Patients with Multiple Sclerosis: A Pilot Trial’ International Journal of MS Care, 2020.

Looking for more information on NeuroTracker research? Feel free to contact us.